FDA Adverse Event Malfunction Summary report: N

EXTRAVASATION DETECTOR SYSTEM

MDR report key: 1380825 · Received March 21, 2009

Report

Report Number
2520313-2009-00011
Event Type
Malfunction
Date Received
March 21, 2009
Date of Event
January 22, 2009
Report Date
March 21, 2009
Manufacturer
MEDRAD, INC.
Product Code
DXT
PMA / PMN Number
NA
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CT, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

MEDRAD SERVICE WENT TO THE SITE TO CHECK OUT THE STELLANT INJECTOR AND THE XDS. NO ISSUES WERE FOUND WITH THE STELLANT INJECTOR. TESTING OF THE EXTRAVASATION DETECTOR'S SCAN ROOM MODULE DETERMINED THAT THE PRODUCT DID NOT PASS ALL FUNCTIONAL TESTING, SO THE SCAN ROOM MODULE WAS RETURNED TO MEDRAD FOR FURTHER ANALYSIS. A FOLLOW-UP REPORT WILL BE SUBMITTED, ONCE THE FINAL INVESTIGATION IS COMPLETE. ADDITIONAL APPLICATION'S TRAINING WAS PERFORMED WITH THE CT STAFF.

Description of Event or Problem · 1

AN OUTPATIENT WAS SCHEDULED FOR A CT SCAN. AN IV WAS STARTED IN THE RIGHT ANTECUBITAL VEIN. THE PT WAS THEN CONNECTED TO A STELLANT D INJECTOR AND THE EXTRAVASATION DETECTOR (XDS). THERE WERE NO ISSUES WITH THE IV AT THE START OF THE INJECTION. THE IV WAS FINE DURING THE SALINE TEST INJECTION AND THE SUBSEQUENT CONTRAST INJECTION. THE TECHNOLOGIST LEFT THE ROOM FOR THE SCAN TO START. NO COMPLAINT FROM PT. WHEN THE TECHNOLOGIST WENT BACK INTO THE ROOM AFTER THE CT SCAN WAS COMPLETE, THERE WAS A LUMP UNDER THE PT SENSOR. THE SITE REPORTED THAT THE EXTRAVASATION WAS APPROXIMATELY 20-30CCS OF SALINE THAT OCCURRED DURING THE SALINE FLUSH (LAST INJECTION PHASE), BECAUSE THE CT IMAGES WERE FINE. THE CUSTOMER REPORTED THAT THE XDS DID NOT DETECT THE SALINE FLUSH EXTRAVASATION. THE PT WAS DISCHARGED WITH INSTRUCTIONS TO APPLY HEAT AND ICE. THE PT DID NOT REQUIRE ANY FURTHER TREATMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 EXTRAVASATION DETECTOR SYSTEM EXTRAVASATION DETECTOR DXT MEDRAD, INC. 3014172 NA

Patients

Seq Age Sex Outcome Treatment
1 76 YR